COMMUNIQUÉS West-GlobeNewswire

Summit’s Pipeline Expands with Series of New Mechanism Antibiotics Targeting Enterobacteriaceae
03/04/2019
Summit Therapeutics plc (‘Summit’ or the ’Company’) Summit’s Pipeline Expands with Series of New Mechanism Antibiotics Targeting Enterobacteriaceae Data to be Presented in Oral Session at ECCMID 2019 Oxford, UK, and [...]
XOMA to Present at the 2019 H.C. Wainwright Global Life Sciences Conference
03/04/2019
EMERYVILLE, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) announced today its Chief Executive Officer, Jim Neal, will present an update about the company’s business at the 2019 H.C. [...]
Editas Medicine and BlueRock Therapeutics Enter Strategic Research Collaboration and Cross-Licensing Agreement to Combine Genome Editing and Cell Therapy Platforms
03/04/2019
– Collaboration enables BlueRock to discover and develop engineered cell medicines broadly across neurology, cardiology and immunology – – Collaboration enables Editas Medicine to discover and develop engineered cell [...]
Sunesis Pharmaceuticals to Present at 18th Annual Needham & Company Healthcare Conference
03/04/2019
SOUTH SAN FRANCISCO, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that Willie Quinn, Chief Financial Officer and Senior Vice President, Finance and Corporate [...]
Emerald Health Therapeutics Signs Letter of Intent to Supply Cannabis to Québec Market
03/04/2019
VANCOUVER, British Columbia, April 03, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has signed a letter of intent to supply cannabis to the Société Québécoise du [...]
Rockwell Medical, Inc. to Present at H.C Wainwright Global Life Sciences Conference
03/04/2019
WIXOM, Mich., April 03, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, will present at the H.C Wainwright [...]
MediPharm Labs Reports Q4 2018 Revenue of $10.2 Million and Adjusted EBITDA of $2.1 Million
03/04/2019
TORONTO, April 03, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, [...]
Dr. Charles Brenner, Discoverer of Nutrient Nicotinamide Riboside as a Vitamin, Announced as Speaker at Upgrade XP’s Sixth Annual Biohacking Conference
03/04/2019
World’s leading expert on NAD metabolism to speak at #UpgradeXP2019 LOS ANGELES, April 03, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today its Chief Scientific Advisor, Dr. Charles Brenner, the [...]
Achillion Announces Enrollment Milestone in Phase 2 Trials for C3 Glomerulopathy
03/04/2019
- Enrolled 23 patients in ACH-4471 Phase 2 C3G six and 12-month clinical trials - - Targeting end-of-Phase 2 meeting with FDA in fourth quarter of 2019 - BLUE BELL, Pa., April 03, 2019 (GLOBE NEWSWIRE) -- Achillion [...]
Veloxis Pharmaceuticals A/S - Passing of Annual General Meeting 2019
03/04/2019
Company Release no. 06/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 03 April 2019 Veloxis Pharmaceuticals A/S - Passing of Annual General Meeting 2019 Summary: At Veloxis Pharmaceuticals A/S’ Annual General [...]
Short report of the status of the review in Oasmia
03/04/2019
Two weeks ago, March 19 th , the Extra General Meeting in Oasmia elected a new Board on the initiative of the main owner Arwidsro. The new Board has since then taken control over the Company and started implementing new [...]
Interim report September 1, 2018 – February 28, 2019
03/04/2019
Company announcement No. 05/2019 Report attached For further information, please contact: Head of Investor Relations Martin Riise Tel.: +45 5339 2250 Investor Relations Officer Annika Stern Tel.: +45 2399 2382 Head of [...]
Dovitinib regulatory strategy confirmed and new combination biomarker DRP PD1/PD-L1 + dovitinib developed. Oncology Venture engages in partnering activities with Destum Partners
03/04/2019
Press release Hoersholm, Denmark, April 3, 2019 – Oncology Venture A/S (Nasdaq First North Stockholm: OV.ST) today announces that the company has confirmed its regulatory strategy of submission of a new drug application [...]
Sandoz resubmits biosimilar pegfilgrastim application to US FDA
03/04/2019
Sandoz pursues US approval for biosimilar pegfilgrastim, a long-acting version of supportive oncology medicine filgrastim Pegfilgrastim is used to reduce the incidence of neutropenia, one of the most serious side [...]
Santhera Provides Update on Near-term Corporate Financing Initiatives
03/04/2019
Pratteln, Switzerland, April 3, 2019 - Santhera Pharmaceuticals (SIX: SANN) announces that it has entered into a CHF 15.0 million credit line facility and is providing an update on ongoing corporate financing [...]
ADMA Receives Department of Health and Human Services U.S. License
03/04/2019
RAMSEY, N.J. and BOCA RATON, Fla., April 02, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical and specialty immunoglobulin [...]
Ken Ludlum Appointed to IRIDEX Board of Directors
03/04/2019
MOUNTAIN VIEW, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced [...]
Veloxis Increases Share Capital in Connection with Exercise of Warrants
02/04/2019
Company Release no. 05/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 02 April 2019 Veloxis Increases Share Capital in Connection with Exercise of Warrants Veloxis Pharmaceuticals A/S announces that the Company's [...]
BODY GLOBE BODY ARMOR® COMPLETES LEVEL II BALLISTICS TEST HOVERINK BIOTECHNOLOGIES ANNOUNCES THEY ARE NOW TAKING PRE-SALE ORDERS
02/04/2019
LOS ANGELES, CA, April 02, 2019 (GLOBE NEWSWIRE) -- Hoverink Biotechnologies, Inc announced today that on February 28, 2019, HP White concluded its level II ballistics test for the U.S. Patent pending: BODY GLOBE BODY [...]

Pages